0
0
0
Transparency in CFPB Cost-Benefit Analysis Act
12/15/2023, 4:07 PM
Summary of Bill S 1362
Bill 118 s 1362, also known as the Transparency in CFPB Cost-Benefit Analysis Act, is a piece of legislation introduced in the US Congress. The bill aims to increase transparency and accountability within the Consumer Financial Protection Bureau (CFPB) by requiring the agency to conduct cost-benefit analyses for its regulations.
Under the provisions of the bill, the CFPB would be required to publish a detailed cost-benefit analysis for each major rule it proposes. This analysis would include an assessment of the potential costs and benefits of the regulation, as well as an evaluation of any potential alternatives that were considered.
The bill also requires the CFPB to consult with other federal agencies, industry stakeholders, and consumer advocates when conducting these analyses. This is intended to ensure that the agency takes into account a wide range of perspectives when developing its regulations. Overall, the Transparency in CFPB Cost-Benefit Analysis Act seeks to promote greater transparency and accountability within the CFPB by requiring the agency to carefully consider the costs and benefits of its regulations before implementing them. This is seen as a way to ensure that the agency's regulations are effective and do not impose unnecessary burdens on consumers or businesses.
Under the provisions of the bill, the CFPB would be required to publish a detailed cost-benefit analysis for each major rule it proposes. This analysis would include an assessment of the potential costs and benefits of the regulation, as well as an evaluation of any potential alternatives that were considered.
The bill also requires the CFPB to consult with other federal agencies, industry stakeholders, and consumer advocates when conducting these analyses. This is intended to ensure that the agency takes into account a wide range of perspectives when developing its regulations. Overall, the Transparency in CFPB Cost-Benefit Analysis Act seeks to promote greater transparency and accountability within the CFPB by requiring the agency to carefully consider the costs and benefits of its regulations before implementing them. This is seen as a way to ensure that the agency's regulations are effective and do not impose unnecessary burdens on consumers or businesses.
Congressional Summary of S 1362
Transparency in CFPB Cost-Benefit Analysis Act
This bill sets forth information required to be included in a rulemaking made by the Consumer Financial Protection Bureau (CFPB). Specifically, the CFPB must publish a justification of the proposed rulemaking; a quantitative and qualitative assessment of all anticipated direct and indirect costs and benefits; alternatives to the proposed rulemaking; impacts on small businesses; and any assumptions, data, or studies used in preparing this information.
Read the Full Bill
Current Status of Bill S 1362
Bill S 1362 is currently in the status of Bill Introduced since April 27, 2023. Bill S 1362 was introduced during Congress 118 and was introduced to the Senate on April 27, 2023. Bill S 1362's most recent activity was Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. as of April 27, 2023
Bipartisan Support of Bill S 1362
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
4Democrat Cosponsors
0Republican Cosponsors
4Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 1362
Primary Policy Focus
Finance and Financial SectorAlternate Title(s) of Bill S 1362
Transparency in CFPB Cost-Benefit Analysis Act
Transparency in CFPB Cost-Benefit Analysis Act
A bill to amend the Consumer Financial Protection Act of 2010 to enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes.
Comments
Sponsors and Cosponsors of S 1362
Latest Bills
To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.
Bill HR 7391February 11, 2026
To amend the Consolidated Farm and Rural Development Act to reauthorize certain water infrastructure grants, and for other purposes.
Bill HR 7476February 11, 2026
To direct the Administrator of the Federal Emergency Management Agency to submit a monthly report on the status of all projects and activities funded through the Disaster Relief Fund, and for other purposes.
Bill HR 7461February 11, 2026
Electing a Member to a certain standing committee of the House of Representatives.
Bill HRES 1048February 11, 2026
To amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified tuition programs for first home purchases, and for other purposes.
Bill HR 7468February 11, 2026
To authorize civil actions against institutions of higher education and athletic associations that negligently or recklessly permit a biologically male student athlete to compete in an athletic competition intended exclusively for female student athletes, resulting in harm.
Bill HR 7368February 11, 2026
ROUTE Act
Bill HR 6642February 11, 2026
To amend section 477 of the Social Security Act to increase the maximum education and training voucher amount and provide greater support for foster youth pursuing postsecondary education.
Bill HR 7463February 11, 2026
Recognizing the cultural and historical significance of Mardi Gras and the celebration's origins in Mobile, Alabama.
Bill HRES 1051February 11, 2026
Home School Graduation Recognition Act
Bill HR 6392February 11, 2026
CFPB Transparency and Accountability Reform Act
Bill HR 2798January 22, 2024
Transparency in CFPB Cost-Benefit Analysis Act
Bill HR 1313January 8, 2024


